Abstract:OBJECTIVE:To evaluate long-term efficacy of half-dose photodynamic therapy on chronic central serous chorioretinopathy using optical coherence tomography. METHODS:A retrospective, interventional case series. Thirty-five eyes of 32 patients (35 eyes) with chronic central serous chorioretinopathy were included, with CSC durations from 6 to 60 months. Patients treated with half-dose verteporfin (3 mg/m(2)) PDT were followed up for 24 months. Best-corrected visual acuity (BCVA), fluorescein angiography (FA), indocyanine green angiography (ICGA) and optical coherence tomography (OCT) pre and post-treatment were all examined to observe the anatomic and functional changes. OCT findings highlighted the alterations of the ellipsoid zone (EZ), the interdigitation zone (IZ) and the central neural retina thickness (CNT) from 3 month to 24 month post-treatment. Regression analysis was applied to determine the correlation between the visual function (BCVA) and structure status (EZ, IZ, CNT). RESULTS:Thirty-five eyes of 32 patients with chronic CSC were treated with half-dose PDT. The logMAR BCVA was 0.53±0.36 at baseline, 0.49±0.39 at 3 months and 0.15±0.38 at 24 months post-PDT. There was no statistical significance between baseline and 3 month BCVA (t=1.952, P>0.05). There existed statistical significance between baseline and 24 month BCVA(t=10.761, P<0.01) as well as 3month and 24 month BCVA(t=8.930, P<0.01). OCT demonstrated the recovery of EZ and IZ. Statistical differences of EZ and IZ integrity degree were found between the 3 month and 24 month (Z=-3.419, -4.082, P<0.01). The mean CNT was (126.8±34.9) μm at baseline. And it kept constant at 3 month [(125.6±34.3)μm] and the 24 month visit [(124.8±35.1)μm]. No statistical significance was found between any two values (t=-1.830, -1.569, 0.793, P>0.05). At baseline, 3 month and 24 month, there was negative correlation between logMAR BCVA and CNT (β=-0.604, -0.634, -0.685, P<0.01) . At 3 month and 24 month, negative correlation between logMAR BCVA and EZ as well as logMAR BCVA and IZ were also found(β=-0.376, -0.394, -0.628, -0.496, P<0.05). A complete resolution of subretinal fluid was noted in 94.3% eyes at 3 month, further increased to 100% eyes at 24 month. The mean session of PDT was 1.03±0.17. CONCLUSIONS:Half-dose PDT was safe and effective for chronic CSC both functionally and morphologically in the long term. Visual benefits may not appear in a short run, yet became remarkable in a long run. Visual benefits might be attributed to recovery of EZ and IZ.

[Evaluation of Photodynamic Therapy in Idiopathic Choroidal Neovascularization].

Extensive Submacular Haemorrhage in Polypoidal Choroidal Vasculopathy Managed by Sequential Gas Displacement and Photodynamic Therapy: a Pilot Study of One‐year Follow Up

[Analysis of RPE Damage after Photodynamic Therapy in Patients with Idiopathic Choroidal Neovascularization].

Multi-factor Analysis of the Effects on Visual Acuity Prognosis of Photodynamic Therapy for Choroidal Neovascularization

Macular function after PDT in myopic maculopathy: psychophysical and electrophysiological evaluation

[Photodynamic therapy for treatment of chronic or recurrent central serous chorioretinopathy].

Small Laser Spot Versus Standard Laser Spot Photodynamic Therapy for Idiopathic Choroidal Neovascularization: a Randomized Controlled Study.

Photodynamic therapy for symptomatic circumscribed macular choroidal hemangioma in Chinese patients.

Gradual healing of macular retinoschisis after photodynamic therapy for choroidal neovascularization in pathological myopia eyes

Short-term Comparison of Tanspupillary Thermotherapy and Photodynamic Therapy for Choroidal Neovascularization in Exudative Age-Related Macular Degeneration

Comparison of One-Year Outcome of Intravitreal Aflibercept with or without Photodynamic Therapy for Polypoidal Choroidal Vasculopathy

Optical coherence tomography for evaluation of photodynamic therapy in symptomatic circumscribed choroidal hemangioma.

Evaluation of Efficacy and Recurrence for Anti-Vascular Endothelial Growth Factor Therapy in Idiopathic Choroidal Neovascularization

Subfoveal Choroidal Thickness after Photodynamic Therapy in Patients with Acute Idiopathic Central Serous Chorioretinopathy

Recent Advances in Photodynamic Therapy for Vascular Abnormalities

Choroidal Neovascularization Emerged Right from the Focal Choroidal Excavation in Eyes with Central Serous Chorioretinopathy Post Half-Dose Photodynamic Therapy: a Case Report

[Observation on Long-Term Efficacy of Half-Dose Photodynamic Therapy with Chronic Central Serous Chorioretinopathy Using Optical Coherence Tomography].

Influence of vortex vein engorgement for photodynamic therapy in central serous chorioretinopathy

OCTA Evaluation of Treatment-Naïve Flat Irregular PED (Fiped)-Associated CNV in Chronic Central Serous Chorioretinopathy Before and after Half-Dose PDT.

Current choroidal neovascularization treatment.

Current Choroidal Neovascularization Treatment